Analyst Expect Big Moves From RAPT Therapeutics Inc (NASDAQ: RAPT)

Currently, there are 34.25M common shares owned by the public and among those 30.23M shares have been available to trade. Insiders at the company have transacted a total of 12 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 8 of these insider trades were purchases, […]